SlideShare ist ein Scribd-Unternehmen logo
1 von 141
PRESENTED BY
MS. SANCHAYEETA DEY
ISO-IMMUNE
DISEASE
• Iso - immune – Means immune disease
in which the antibodies are produced as
a result of antigens from another person.
• Autoimmune – in which the antigens
come from the same person.
•The differences in human blood are due to the
presence or absence of certain protein molecules
called antigens and antibodies.
•The antigens are located on the surface of the
RBCs and the antibodies are in the blood plasma.
•Individuals have different types and
combinations of these molecules.
•The blood group you belong to depends on what
you have inherited from your parents.
•There are more than 20 genetically determined
blood group systems known today
Eg. ABO System,Rh-System, MNS System, Kell
System, Lewis System
•The AB0 and Rhesus (Rh) systems are the most
important ones used for blood transfusions.
•Not all blood groups are compatible with each other.
Mixing incompatible blood groups leads to blood
clumping or agglutination, which is dangerous for
individuals.
Major Blood Grouping System:
⚫ ABO blood group system
⚫ Rh blood group system because they cause
major transfusion reaction.
Minor Blood Grouping System:
⚫ MNS blood group system
⚫ Blood group system because they cause minor
transfusion reaction.
Familial Blood Grouping System:
⚫ Kell, Daffy, Lutheran, Lewis, Deigo, and Many
more.
According to the ABO blood
typing system there are four
different kinds of blood types: A,
B, AB or O (null).
• It was given by Karl Landsteiner in 1900.
• It states that ; If an agglutinogen is
present on the RBC of an individual, the
corresponding agglutinin must be absent
in the plasma of that individual and vice-
versa.
• This law is only applicable to ABO blood
grouping system.
Blood group A
If you belong to the blood
group A, you have A
antigens on the surface of
your RBCs and B
antibodies in your blood
plasma.
Blood group B
If you belong to the blood
group B, you have B
antigens on the surface of
your RBCs and A
antibodies in your blood
plasma.
Blood group AB
If you belong to the blood group AB,
you have both A and B antigens on
the surface of your RBCs and no A
or B antibodies at all in your blood
plasma.
Blood group O
If you belong to the blood group O
(null), you have neither A or B
antigens on the surface of your RBCs
but you have both A and B antibodies
in your blood plasma.
Blood
Group
Antigens Antibodies Can give
blood to
Can receive
blood from
AB A and B None AB AB, A, B, O
A A B A and AB A and O
B B A B and AB B and O
O None A and B AB, A, B, O O
Blood group O is called
"universal donor"
because it has no antigens
on RBC.
Blood group AB are called
"universal
receivers“ because it has
no anti- bodies in the
plasma.
• The Rhesus factor gets its name from
experiments conducted in 1937 by scientists
Karl Landsteiner and Alexander S. Weiner.
• Their experiments involved rabbits which,
when injected with the Rhesus monkey's red
blood cells, produced an antigen that is
present in the red blood cells of many
humans.
•The genotype is determined by the inheritance of 3
pairs of closely linked allelic genes situated on
chromosome 9 named as
D/d,
C/c,
E/e
……….. (Fisher- Race theory)
• A condition that occurs during pregnancy if
a blood and her blood. Mother’s body
create Rh antibodies against the baby’s
blood.
• Also known as haemolytic disease of the
fetus and newborn(HDFN).
18
• First demonstrated in rhesus monkey
• Blood groups are classified as Rh
positive and Rh negative
•The Rh factor , Rh+ and Rh- usually refers
specifically to the presence or absence of antigen-
D
•There are two alleles, or genetic variants , of this
antigen: D and d.
•A person who is Rh- has two recessive traits, dd.
Anyone who has at least one D-DD or Dd-is Rh+
• A person's Rh type is generally most relevant
with respect to pregnancies
• If the pregnant woman and her husband are
Rh negative, there is no reason to worry about
Rh incompatibility
•If she is Rh negative and her husband is Rh
positive,the baby will inherit the father's blood
type ,creating incompatibility between mother
and her fetus.
•If some of the fetal blood gets into mother's
blood stream, her body will produce antibodies.
•These antibodies could pass back through the
placenta and harm the developing baby's red
blood cells, causing very mild to very serious
anemia in the fetus.
23
1.Rh-ve mothercarryingRh+ve
fetus
2.Entry of fetus Rh+ve RBC into
maternalcirculation
3.Development of Rh antibodies
by the mother
•Usually placenta acts as barrier to fetal blood entering
maternal circulation. However, sometimes during
pregnancy or birth,fetomaternal haemorrhage (FMH)
can occur. The woman’s immune system reacts by
producing anti-D antibodies that cause sensitisation
•In subsequent pregnancies antibodies can cross placenta
and destroy fetal erythrocytes. The haemolytic disease of
fetus and new born caused by Rh isoimmunisation can
occur during the first pregnancy, but usually sensitisation
during the first pregnancy or birth leads to extensive
destruction of fetal RBC during subsequent pregnancies
• Miscarriage
• Abortion
• Feto-maternal haemorrage
• Rh incompatibility can cause symptoms ranging
from very mild to fatal.
• Mildest form- Rh incompatibility:
1-Hemolysis (Destruction of the red blood cells)
with the release of free hemoglobin into the
infant's circulation.
2- Jaundice (Hemoglobin is converted into,bilirubin
which causes an infant to become yellow.
1- Hydrops fetalis (Massive fetal
red blood cell destruction).
It causes
anemiaFetal heart
failure Death of the infant
shortly after delivery.
3 Respiratory distress (if the infant has been delivered)
4 Circulatory collapse.
5 Kernicterus. (Neurological syndrome in extremely
jaundiced infants)
6 It occurs several days after delivery and is
characterized initially by...
A)Loss of the Moro reflex.
B)Poor Feeding.
C) Decreased activity
• At last it may lead to death of the child
immediately after its birth
1 There are no any physical symptoms can be seen
in rh incompatibility.
2 If the woman just found out she is pregnant,she
should undergo blood-type test. This test
determines her blood type and Rh factor.
3 Blood test that will determine whether she is Rh
positive or Rh negative
• Intrauterine transfusion
• Elect time of delivery
• Exchange transfusion after delivery
• Phototherapy after delivery
• Top-up transfusion
(Hb falls below 7g/dl, prophylactic :oral folate)
36
• The fetus can die in utero from severe anaemia and
hydrops before he can be delivered.
• An intrauterine transfusion can prolong the life in
utero of a fetus to a gestation where the risks of
prematurity are estimated as being less than those
of the Rh disease. This can be done by an:
1.Intraperitoneal transfusion guidedby ultrasound.
2.Umbilical veintransfusion guided by ultrasound.
37
Rh-negative
blood
is either transfused
under ultrasoundcontrol. Repeat as
necessary, accordingto amniotic optical
density, or fetal haematocrit. The
intravenous route is becoming increasingly
the preferred method.
Choose time of induction and best
method of delivery
• Balance the risks of prematurity (too soon) with
that of worsening Rh disease (too late).
• Consider the risks of vaginal delivery and be
prepared for a lower segment Caesarean section
(LSCS).
• Usually done only after 34 weeks of gestation.
• The paediatric team should be in close and a
senior paediatrician present at the delivery
• Fresh Rh-negative blood available.
39
• Good resuscitation is
essential. In an anaemic.
premature infant, lung
disease is common. It can
be due to:
 Surfactant deficiency at
very early delivery.
 Pulmonary oedema from
anaemia and
hypoproteinaemia.
 Hypoplastic lungs
secondary to pleural
effusions.
• In severe Rh haemolytic
disease of the newborn, an
umbilical artery catheter
should be inserted as soon
as possible to assess and
control PaO2 and pH.
• Central venous pressure
should be measured.
 Drain pleural effusions and
ascites at resuscitation.
40
Indication for exchange
Transfusion:
1. Early: Decisionmainly based
oncord
(in addition consider history of
previously affected babies).
• Cord haemoglobin <12g/dl.
• Strongly positive Coombs’ test.
• Cord bilirubin >85mmol/l.
2.HaemoglobinLate:
Usually donefor
hyperbilirubinaemia.
• The aims:
 Treat anaemia.
 Washes out IgG antibodies.
 Decreases degree of
haemolysis.
 Removes bilirubin.
 Prevents kernicterus.
• Placing newborn baby under a halogen or
fluorescent lamp with their eyes covered.
• Lowers the bilirubin levels in the baby’s blood
through photo-oxidation.
• During phototherapy, intravenous hydration is
required.
42
• Anti-D immunoglobulin to all Rh-negative women
at 28 and 34 weeks routinely-RAADP Or give anti-
D immunoglobulin
if she has a:
 Therapeutic abortion.
Spontaneous abortion/ectopic pregnancy.
 Amniocentesis.
 Any bleeding in pregnancy/threatened miscarriage.
 External Cephalic Version.
 After delivery at any gestation within 72Hours.
44
DIAGNOSIS
Risk for injury from breaking down products of RBCs
in greater numbers than normal and functional
immaturity of the liver.
Goals
• Will receive appropriate therapy to accelerate
bilirubin excretion.
• Will experience no complications from phototherapy.
• Will experience no complications from exchange
transfusin.
• Interrupted family process R/T infant with
potentially adverse physiologic response.
• Family will receive emotional support.
• Family will be prepared for home care of the
neonate.
• NURSING CARE for Rh incompatibility DURING
PHOTOTHERAPY
1.Remove clothing to proper skin exposure.
2.Turn infant frequently to expose all skin area.
3.Record and report jaundice and blood levels of
bilirubin.
4.Record and report if any change in body
temperature
-Be sure the eyes close before applying eye patch
to prevent corneal irritation.
-Should be loose enough to avoid pressure.
-Eye patches should be changed every 8houly and
eye care given.
6.Nurse should expect the infant’s stools to be
green and the urine dark because of photo
degradation products.
7. Serum bilirubin and hematocrit should be
monitored during therapy and for 24 hours
following therapy.
8. In case of breast milk jaundice stop breast
feeding temporarily.
9. Maintain feeding intervals to prevent
dehydration.
Oct-15 Rhesus Incompatibility 53
• In addition to cases in which a fetus dies during
delivery as
deprivation
a result of asphyxia
if the umbilical cord
(oxygen
becomes
twisted) or difficult labor.
• Others can die in utero before labor starts.
followed by expulsion of the fetus from the
uterus within a few days.
• However, in rare instances the dead fetus is not
expelled from the uterus at once, but is retained
for several weeks.
• Fetal death refers to the spontaneous death of
a fetus at any time during pregnancy, although
the term is often used interchangeably with
‘stillbirth’.
• A stillbirth is a death that occurs after 20
weeks of gestation.
Intrauterine fetal death: is the clinical term for
the death of a baby in the uterus, during
pregnancy and before birth. The term is
usually used for pregnancy losses that
happen after the 20th week of gestation.
•In the present investigation the epidemiological
factors responsible for intrauterine fetal deaths
after 20 week of gestation were studied.
•A retrospective study
registered and managed
of 16882 pregnancies
in the Department of
Obstetrics and Gynecology, in united state
One hundred and three cases of intrauterine
fetal deaths were registered and treated
expectantly out of 16882 total pregnancies
registered during the four year study period.
Pregnancy complications:
- Pre-eclamptic toxemia
- Antepartum haemorrhage : placenta previa,
abruptio placentae
Pre- existing medical disease and acute
illness:
- Chronic hypertension
- Chronic nephritis
- Diabetes
- Severe anemia
- Hyperpyrexia
- Syphilis, Hepatitis, toxoplasmosis etc.
Hyperpyrexia
• Fetal
- Congenital malformation
- Rh-incompatibility
- Post maturity
• External version
• Idiopathic 20 –30%
• Maternal Complications
• Decreased platelets
• Decreased fibrinogen
• Increased PT/PTT (Clotting times)
• Clinical bleeding / oozing from all sites
RX involves DELIVERY, pRBC’s, FFP, PLATELETS,
Supportive Management
• Depression, Anxiety, Psychosocial
• Anxiety with future pregnancies
• May have repeat losses (depending on causes)
• Bleeding ---> can lead to DIC but may only
require blood product replacement
• Pain, Infection (similar to any other delivery)
•Multiple pregnancy
•Advanced maternal age
•History of fetal demise (IUFD)
•Maternal infertility
•Maternal haemoconcentration
•Maternal colonization with certain pathogens
•Small for gestational age infant
•Obesity
•Paternal age
•African American race
• Absence of fetal movement
• Vaginal bleeding
• Abdominal pain
• Small uterus than the duration of pregnancy
• Sometimes secretion of colostrum occur few
days after death of fetus in uterus.
• In most patients, the only symptom is decreased
fetal movement. An inability to obtain fetal heart
tones upon examination suggests fetal demise;
however, this is not diagnostic and death must be
confirmed by diagnostic tests .
• Labor should be induced as soon as possible after
diagnosis. Patient responses vary in regard to this
recommendation; some wish to begin induction
immediately, while others wish to delay induction
for a period of hours or days until they are
emotionally prepared.
• Blood test because it comes negative within a
week after the death of the fetus.
• The secretion of estriol it is a type of estrogen
produced by an active placenta in the
mother’s urine falls sharply.
• Explain the problem to the woman and her
family. Discuss with them the options of
expectant or active management.
• Medical induction of labor: Medicine is used
to start labor and fetus delivered naturally.
• Pain management in patients undergoing
induction of labor for fetal death is usually easier
to manage than in patients with live fetuses.
• Higher doses of narcotics are available to the
patient and often a morphine is sufficient for
successful pain control. Should a patient desire
superior pain control to intravenous narcotics,
epidural anesthesia should be offered.
Diagnosis
Anticipatory grieving related to fetal loss
Intervention
• To give the patient time to gather support
from her family and to fathom the reality of
the situation.
• Provide psychological support.
• Provide counseling to the mother as well as
family.
Nursing health care guidelines at home
• Teach the patient to be aware of the signs and
symptoms that could indicate postpartum
complications:
• Pain in the calf of the leg; increase in vaginal
bleeding; foul odor of vaginal discharge; fever;
burning with urination; persistent mood charge;
or a hard, reddened area on the breast.
• Explain that the patient
intercourse or drive a car until
should not have
after the
postpartum check.
• Encourage participation in a bereavement
support group, even if the patient and
significant other seem to be coping with the
loss.
• They may be able to help other couples cope.
SGA
• Cellular hyperplasia
• Hyperplasia and hypertrophy
• Hypertrophy
• Stage I (Hyperplasia)
- 4 to 20 weeks
- Rapid mitosis
- Increase of DNA content
• Stage II (Hyperplasia & Hypertrophy)
- 20 to 28 weeks
- Declining mitosis.
- Increase in cell size.
• Stage III ( Hypertrophy)
- 28 to 40 weeks
- Rapid increase in cell size.
- Rapid accumulation of fat, muscle and
connective tissue.
• 95% of fetal weight gain occurs during last 20
weeks of gestations.
• Maternal factors
• Fetal factors
• Placental factors
• Environmental factors
•Medical disease
•Malnutrition  BMI < 19 twice the risk of
IUGR
•Multiple pregnancy
•Smoking (460 gm < then none smoker)
•Alcohol
•Drugs
second
 12-fold increase risk of IUGR
 Beta- Blockers(Atenolol in
trimster, Anticoagulants,
Anticonvulsants( phenytoin)
•Hypoxemia
•Infections  UTI, Malaria,
Infections
TB, Genital
• Small stature/ low pre-pregnancy weight
• Teen pregnancy
• Primi gravida
• Grand multiparity
• A Chromosome Defect-
 In second trimester 20% SGA fetuses
have chromosomal abnormality



Triploid is most common under 26 wks.
Trisomy-18 is common after 26 wks .
Other are 21(Down’s syndrome), 16, 13,
xo (turner’s syndrome).
• Exposure to an infection-
• German measles (rubella), cytomegalovirus,
herpes simplex, tuberculosis, syphilis, or
toxoplasmosis, TB, Malaria, Parvo virus
• birth defects
• (cardiovascular, renal, anencephally, limb
defect, etc).
• A primary disorder of bone or cartilage.
• A chronic lack of oxygen during development
(hypoxia
• Placenta or umbilical cord defects.
• Uteroplacental Insufficiency Resulting
From -.
–Improper / inadequate trophoblastic
invasion and placentation in the first
trimester.
–Lateral insertion of placenta.
–Reduced maternal blood flow to the
placental bed.
• Fetoplacetal Insufficiency Due To-.
–Vascular anomalies of placenta and cord.
–Decreased placental functioning mass-.
• Small placenta, abruptio placenta,
placenta previa, post term pregnancy
• High altitude - lower environmental oxygen
saturation
• Toxins
•Symmetric IUGR (33
% of IUGR Infants)
•Asymmetric IUGR
(55 % of IUGR)
•Combined type IUGR
(12 % of IUGR)
• Height, weight, head circ proportional
• Early pregnancy insult:
• Commonly due to congenital infection, genetic
disorder, or intrinsic factors
• Reduced no of cells in fetus
• Normal ponderal index
• Low risk of perinatal asphyxia
• Low risk of hypoglycemia
• The ponderal index is used determine those
infants
normal
whose
for
soft tissue mass is
their
below
stage of skeletal
development.
Ponderal Index = birth weight x 100
crown-heel length
• Typical values are 20 to 25.
• Those who have a ponderal index below the
10th % can be classified as SGA
• PI is normal in symmetric IUGR.
• PI is low in asymmetric IUGR
• Later in pregnancy:
• Commonly due to utero placental
insufficiency, maternal malnutrition, hypoxia,
or extrinsic factors
• Low ponderal index
• Cell number remains same but size is small
• Increased risk of asphyxia
• Increased risk of hypoglycemia
• Growth restriction in the stage of hypertrophy
• Brain sparing effect
• Head growth remains normal but abdominal
girth slows down
1. Normal Small Fetuses-
• Have no structural abnormality,
umbilical artery & liquor but wt., is
less.
normal
• They are not at risk and do not need any special
care.
Growth Restricted Fetuses- are due to impaired
function. Appropriate & timely
or termination can improve
placental
treatment
prospects.
Dry wrinkled skin
Large head circumference
Old man look
Cartilaginous ridges on pinna
Open eyes
Thin umbilical cord
Well defined creases
Normal reflexes
Alert and active
Normal cry
• Scaphoid abdomen
• Signs of recent wasting
- soft tissue wasting
- diminished skin fold thickness
- decrease breast tissue
- reduced thigh circumference
• Signs of long term growth failure
- Widened skull sutures, large fontanelles
- shortened crown – heel length
- delayed development of epiphyses
• History
• Risk factors
• Last menstrual period - most precise size of
uterus
• Time of quickening (detection of fetal
movements)
• Examination
• Maternal serum screening
- Notching of the waveform /reduce EDF
associated 3-fold increase in risk of FGR.
• Combination of un-explain elevated maternal AFP
is powerful predictor of adverse perinatal
outcome (FGR)
• Increase AFP combine with echogenic bowel is
strong predictor of FGR
• DOPPLER OF THE UMBILICAL ARTERY
• Reduced end diastolic flow.
• Absent end diastolic flow
• Reversed end diastolic flow( severe cases)
• Hypoxia
- Perinatal asphyxia
- Persistent pulmonary hypertension
- meconium aspiration
• Thermoregulation
-Hypothermia due to diminished
subcutaneous fat and elevated
surface/volume ratio
- Hypoglycemia
- result from inadequate glycogen stores.
- diminished gluconeogenesis.
- increased BMR
- Hypocalcemia
- due to high serum glucagon level, which
stimulate calcitonin excretion
• Hematologic
-hyperviscosity and polycythemia due to
increase erythropoietin level sec. to hypoxia
• Immunologic
-IUGR have increased protein catabolism and
decreased in protein, prealbumin and
immunoglobulins, which decreased humoral
and cellular immunity.
• Fetal distress,
• Hypoxia, Acidosis and Low Apgar Score at
birth.
Increased perinatal morbidity and mortality
• Grade 3-4 intraventricular haemorrhage
• Necrotizing enterocolitis
• BIOPHYSICAL
• HC:AC
• Brfore 32 wks
• 32—34 wks
more than 1
app 1
• FEMUR LENGTH
• FL:AC IS 22at all gest wks from 21 wks to term
• More than 23.5 indicate IUGR
• AFI
• <2 Suggest IUGR
• PI
• MUMMIFICATION
• KMC
• NESTING
• DELAY BATH
• WARMER
• VENTILATOR
• C PAP
• 02 SUPPLEMENTATION
• <30– IV FLUIDS, NG ,KATORI, BREAST FEEDS
• 30—34 NG ,KATORI, BREAST FEEDS
• >34 KATORI, BREAST FEEDS
• Vital signs
• Activity and behaviour.
• Color; Pink, pale, grey, blue, yellow.
• Tissue perfusion
• Fluids, electrolytes and ABG's.
• Bronchopulmonary dysplasia
• Metabolic disturbances and hypoglycemia
• Polycytemia
• Hypothermia
• Impaired cognitive function and cerebral
paresis
• ASPIRIN THERAPY
• Other forms of treatment that have been
studied are
• nutritional supplementation,
• zinc supplementation,
• fish oil,
• hormones and
• oxygen therapy
Diagnosis
• Impaired nutritional status less then body
requirement related to malnutrition.
Intervention
• To correct malnutrition by providing balanced
diet.
• To take extra calories from normal i.e. 300
calories extra.
• To provide nutritious foods, juices, fruits etc.
Diagnosis
• Decreased uteroplacental circulation related
to reduced blood flow to maternal surface or
placental cause.
Intervention
• Adequate bed red in left lateral position.
• Provide low dose of aspirin i.e. 50 mg daily.
• Prove o2 to mother at the rate of 2.5 L/min by
nasal prong for short term for prolongation of
pregnancy.
Diagnosis
• Decreased knowledge status of mother
related to IUGR, its complication to baby.
Intervention
• Provide knowledge to the mother.
• Provide health education to mother related to
self care as well as related to diet.
• Provide detailed information about her
condition of baby as well as complication for
baby.
Risk for infection related to poor immunity
Goal
Care at neonatal intensive care unit
Intervention
• The NICU should be warm, free from excessive sound
smoothing light.
• Protection from infection should be ensured by aseptic
measures and effective hand washing.
• Rough handling and painful procedure should be
avoided.
• Baby should be placed on soft comfortable, “nestled”
and cushioned bed.
• Continuous monitoring of the baby’s clinical status are
vital aspects.
Decreased body temperature related to IUGR
Goal
Maintenance of stable body temperature
Intervention
• Baby should be received in a pre warmed radiant
warmer or incubator. Environmental temperature
should be maintained according to baby’s weight
and age.
• Baby’s skin temperature should be maintained 36.5
to 37.5 degree celcious.
• Baby birth weight of less than 1200gm should be
cared in the NICU incubator with 60 to 70 %
humidity, oxygen and thermo nutral environment
for better thermal control and prevent heat loss.
Decreased body weight of baby related to IUGR.
Goal
Maintenance of nutrition and hydration
Intervention
• Caloric needs of non-growing LBW babies during first
week of life are 60 kcal/ kg/ day on 7th is to be
stepped up gradually to 100 on 14th day and about
120-150 on 21st day, to maintain satisfactory
growth.
• Human milk is the first choice of nutrition for all LBW
babies. Colostrums, hind milk, foremilk, and preterm
milk help faster growth of baby.
• If breast milk is not available cows milk in proportion
of 1:1 (milk: water) for 1st month and 2:1 during
second month is an alternative substitute.
AND
SUMMARY
TITLE - Study of causes and complications of intra
uterine fetal death (IUFD)
OBJECTIVES - This study were to study the causes of
Intra Uterine Fetal Death (IUFD), associated
complications and to suggest preventive measures.
METHODS - Study design: retrospective observational
study. This study was carried out over a period of 3
months (April 2014- June 2014) at a tertiary care
hospital. Inclusion criteria was all IUFD >20 weeks of
gestation.
Out of 1850 total births during the study period
80 IUFD occurred. Hence proportion of IUFD
was 4.3%. In this study, Still Birth Rate (SBR) as
per WHO criteria (28 weeks) was 22.1 per 1000.
Registered patients were 24 (30%) whereas 56
(70%) were emergency admissions. Majority of
cases, 48 (60%) were multigravidae with past
obstetric history of abortion and IUFD in 13
(16.2%) and 9 (11.2%) respectively. In 31
(38.7%) no identifiable cause of IUFD was found
whereas cause was identified in 49 (61.3%).
 who
had
who had
 care.A significant proportion of IUFD is
Anemia, PIH, accidental haemorrhage were
leading causes of IUFD. Majority of women
IUFD were emergency admission
not received adequate antenatal
preventable by health education to patients
and community for regular antenatal care,
about warning signs during antenatal period,
hospital delivery and early referral.
ISO IMMUNE DISEASE.pptx
ISO IMMUNE DISEASE.pptx

Weitere ähnliche Inhalte

Was ist angesagt?

Rh Incompatibility
Rh IncompatibilityRh Incompatibility
Rh Incompatibility
dlsupport
 
blood transfusion in neonates (British society of hematology)
blood transfusion in neonates (British society of hematology)blood transfusion in neonates (British society of hematology)
blood transfusion in neonates (British society of hematology)
Souhila Bait
 

Was ist angesagt? (20)

hemolytic disease of new born
hemolytic disease of new born hemolytic disease of new born
hemolytic disease of new born
 
Hemolytic disease of newborn
Hemolytic disease of newbornHemolytic disease of newborn
Hemolytic disease of newborn
 
Exchange blood transfusion
Exchange blood transfusionExchange blood transfusion
Exchange blood transfusion
 
Abo incompatibility
Abo incompatibilityAbo incompatibility
Abo incompatibility
 
HMFs
HMFsHMFs
HMFs
 
Neonatal Cholestasis
Neonatal CholestasisNeonatal Cholestasis
Neonatal Cholestasis
 
Haemolytic disease of new born
 Haemolytic disease of new born Haemolytic disease of new born
Haemolytic disease of new born
 
Rh Incompatibility
Rh IncompatibilityRh Incompatibility
Rh Incompatibility
 
seminar on anemia in newborn
seminar on anemia in newbornseminar on anemia in newborn
seminar on anemia in newborn
 
Neonatal thrombocytopenia
Neonatal thrombocytopeniaNeonatal thrombocytopenia
Neonatal thrombocytopenia
 
Hemolytic disease of newborn Lecture Final Year MBBS
Hemolytic disease of newborn Lecture Final Year MBBS Hemolytic disease of newborn Lecture Final Year MBBS
Hemolytic disease of newborn Lecture Final Year MBBS
 
Rh alloimmunization
Rh alloimmunizationRh alloimmunization
Rh alloimmunization
 
Rh iso immunization
Rh  iso immunization Rh  iso immunization
Rh iso immunization
 
Seminar on neonatal cholestasis
Seminar on neonatal cholestasisSeminar on neonatal cholestasis
Seminar on neonatal cholestasis
 
Abo incompatibility
Abo incompatibility Abo incompatibility
Abo incompatibility
 
Isoimmunization
IsoimmunizationIsoimmunization
Isoimmunization
 
blood transfusion in neonates (British society of hematology)
blood transfusion in neonates (British society of hematology)blood transfusion in neonates (British society of hematology)
blood transfusion in neonates (British society of hematology)
 
Approach to a child with suspected Immunodeficiency
Approach to a child with suspected ImmunodeficiencyApproach to a child with suspected Immunodeficiency
Approach to a child with suspected Immunodeficiency
 
Approach to a child with failure to thrive
Approach to a child with  failure to thriveApproach to a child with  failure to thrive
Approach to a child with failure to thrive
 
Bind
BindBind
Bind
 

Ähnlich wie ISO IMMUNE DISEASE.pptx

Hemolytic disease of the newborn
Hemolytic disease of the newbornHemolytic disease of the newborn
Hemolytic disease of the newborn
Jinky Rose Ricasio
 
Essentials of blood group.pptx remedial biology
Essentials of blood group.pptx remedial biologyEssentials of blood group.pptx remedial biology
Essentials of blood group.pptx remedial biology
Rakesh Barik
 

Ähnlich wie ISO IMMUNE DISEASE.pptx (20)

Iso immune disease
Iso immune diseaseIso immune disease
Iso immune disease
 
RH ISOIMMUNIZATION BWIRE2.pptx
RH ISOIMMUNIZATION BWIRE2.pptxRH ISOIMMUNIZATION BWIRE2.pptx
RH ISOIMMUNIZATION BWIRE2.pptx
 
Hemolytic disease of the newborn
Hemolytic disease of the newbornHemolytic disease of the newborn
Hemolytic disease of the newborn
 
Lecture 27- Blood Group.pptx
Lecture 27- Blood Group.pptxLecture 27- Blood Group.pptx
Lecture 27- Blood Group.pptx
 
Blood group
Blood groupBlood group
Blood group
 
Blood group
Blood groupBlood group
Blood group
 
Document (17).pdf
Document (17).pdfDocument (17).pdf
Document (17).pdf
 
Blood group
Blood groupBlood group
Blood group
 
Iso immunization
Iso immunizationIso immunization
Iso immunization
 
Rh incompatibility
Rh incompatibilityRh incompatibility
Rh incompatibility
 
Blood grouping
Blood grouping Blood grouping
Blood grouping
 
Rhesus Isoimmunisation Dr Adegoke.pptx
Rhesus Isoimmunisation Dr Adegoke.pptxRhesus Isoimmunisation Dr Adegoke.pptx
Rhesus Isoimmunisation Dr Adegoke.pptx
 
ISO IMMUNIZATION IN PREGNANCY
ISO IMMUNIZATION IN PREGNANCYISO IMMUNIZATION IN PREGNANCY
ISO IMMUNIZATION IN PREGNANCY
 
Immunohematology
ImmunohematologyImmunohematology
Immunohematology
 
Rh incom .ppt
Rh incom .pptRh incom .ppt
Rh incom .ppt
 
1569612387419 physiology[1]
1569612387419 physiology[1]1569612387419 physiology[1]
1569612387419 physiology[1]
 
Hdfn
HdfnHdfn
Hdfn
 
Blood group and typing 2021
Blood group and typing 2021Blood group and typing 2021
Blood group and typing 2021
 
Blood groups
Blood groupsBlood groups
Blood groups
 
Essentials of blood group.pptx remedial biology
Essentials of blood group.pptx remedial biologyEssentials of blood group.pptx remedial biology
Essentials of blood group.pptx remedial biology
 

Mehr von SANCHAYEETA2

Mehr von SANCHAYEETA2 (13)

SEMINAR ON NORMS.pptx
SEMINAR ON NORMS.pptxSEMINAR ON NORMS.pptx
SEMINAR ON NORMS.pptx
 
SOCIAL STRUCTURE.pptx
SOCIAL STRUCTURE.pptxSOCIAL STRUCTURE.pptx
SOCIAL STRUCTURE.pptx
 
ANATOMY AND PHYSIOLOGY OF FEMALE REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF FEMALE REPRODUCTIVE SYSTEM.pptxANATOMY AND PHYSIOLOGY OF FEMALE REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF FEMALE REPRODUCTIVE SYSTEM.pptx
 
obstetrical emergencies PPT.pptx
obstetrical emergencies PPT.pptxobstetrical emergencies PPT.pptx
obstetrical emergencies PPT.pptx
 
PPT OF MINOR AILMENTS OF PREGNANCY.pptx
PPT OF MINOR AILMENTS OF PREGNANCY.pptxPPT OF MINOR AILMENTS OF PREGNANCY.pptx
PPT OF MINOR AILMENTS OF PREGNANCY.pptx
 
objective test scoring and essay scoring
objective test scoring and essay scoringobjective test scoring and essay scoring
objective test scoring and essay scoring
 
Importance of clinical leadership and management.pptx
Importance of clinical leadership and management.pptxImportance of clinical leadership and management.pptx
Importance of clinical leadership and management.pptx
 
PHYSIOLOGY OF PUERPERIUM.pptx
PHYSIOLOGY OF PUERPERIUM.pptxPHYSIOLOGY OF PUERPERIUM.pptx
PHYSIOLOGY OF PUERPERIUM.pptx
 
MINOR DISORDERS OF PREGNANCY NEW.pptx
MINOR DISORDERS OF PREGNANCY NEW.pptxMINOR DISORDERS OF PREGNANCY NEW.pptx
MINOR DISORDERS OF PREGNANCY NEW.pptx
 
STAFFING.pptx
STAFFING.pptxSTAFFING.pptx
STAFFING.pptx
 
PPT DISCUSSION ON ISSUES OF MATERNAL AND CHILD HEALTH.pptx
PPT DISCUSSION ON ISSUES OF MATERNAL AND CHILD HEALTH.pptxPPT DISCUSSION ON ISSUES OF MATERNAL AND CHILD HEALTH.pptx
PPT DISCUSSION ON ISSUES OF MATERNAL AND CHILD HEALTH.pptx
 
BIRTH ASPHYXIA PPT.pptx
BIRTH ASPHYXIA PPT.pptxBIRTH ASPHYXIA PPT.pptx
BIRTH ASPHYXIA PPT.pptx
 
PPT EVALUATION STRATEGIES IN CURRICULUM.pptx
PPT EVALUATION STRATEGIES IN CURRICULUM.pptxPPT EVALUATION STRATEGIES IN CURRICULUM.pptx
PPT EVALUATION STRATEGIES IN CURRICULUM.pptx
 

Kürzlich hochgeladen

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
SoniaTolstoy
 

Kürzlich hochgeladen (20)

Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
General AI for Medical Educators April 2024
General AI for Medical Educators April 2024General AI for Medical Educators April 2024
General AI for Medical Educators April 2024
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
9548086042 for call girls in Indira Nagar with room service
9548086042  for call girls in Indira Nagar  with room service9548086042  for call girls in Indira Nagar  with room service
9548086042 for call girls in Indira Nagar with room service
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 

ISO IMMUNE DISEASE.pptx

  • 1. PRESENTED BY MS. SANCHAYEETA DEY ISO-IMMUNE DISEASE
  • 2. • Iso - immune – Means immune disease in which the antibodies are produced as a result of antigens from another person. • Autoimmune – in which the antigens come from the same person.
  • 3.
  • 4. •The differences in human blood are due to the presence or absence of certain protein molecules called antigens and antibodies. •The antigens are located on the surface of the RBCs and the antibodies are in the blood plasma. •Individuals have different types and combinations of these molecules. •The blood group you belong to depends on what you have inherited from your parents.
  • 5. •There are more than 20 genetically determined blood group systems known today Eg. ABO System,Rh-System, MNS System, Kell System, Lewis System •The AB0 and Rhesus (Rh) systems are the most important ones used for blood transfusions. •Not all blood groups are compatible with each other. Mixing incompatible blood groups leads to blood clumping or agglutination, which is dangerous for individuals.
  • 6. Major Blood Grouping System: ⚫ ABO blood group system ⚫ Rh blood group system because they cause major transfusion reaction. Minor Blood Grouping System: ⚫ MNS blood group system ⚫ Blood group system because they cause minor transfusion reaction. Familial Blood Grouping System: ⚫ Kell, Daffy, Lutheran, Lewis, Deigo, and Many more.
  • 7. According to the ABO blood typing system there are four different kinds of blood types: A, B, AB or O (null).
  • 8. • It was given by Karl Landsteiner in 1900. • It states that ; If an agglutinogen is present on the RBC of an individual, the corresponding agglutinin must be absent in the plasma of that individual and vice- versa. • This law is only applicable to ABO blood grouping system.
  • 9. Blood group A If you belong to the blood group A, you have A antigens on the surface of your RBCs and B antibodies in your blood plasma. Blood group B If you belong to the blood group B, you have B antigens on the surface of your RBCs and A antibodies in your blood plasma.
  • 10. Blood group AB If you belong to the blood group AB, you have both A and B antigens on the surface of your RBCs and no A or B antibodies at all in your blood plasma. Blood group O If you belong to the blood group O (null), you have neither A or B antigens on the surface of your RBCs but you have both A and B antibodies in your blood plasma.
  • 11.
  • 12. Blood Group Antigens Antibodies Can give blood to Can receive blood from AB A and B None AB AB, A, B, O A A B A and AB A and O B B A B and AB B and O O None A and B AB, A, B, O O
  • 13. Blood group O is called "universal donor" because it has no antigens on RBC. Blood group AB are called "universal receivers“ because it has no anti- bodies in the plasma.
  • 14.
  • 15. • The Rhesus factor gets its name from experiments conducted in 1937 by scientists Karl Landsteiner and Alexander S. Weiner. • Their experiments involved rabbits which, when injected with the Rhesus monkey's red blood cells, produced an antigen that is present in the red blood cells of many humans.
  • 16. •The genotype is determined by the inheritance of 3 pairs of closely linked allelic genes situated on chromosome 9 named as D/d, C/c, E/e ……….. (Fisher- Race theory)
  • 17. • A condition that occurs during pregnancy if a blood and her blood. Mother’s body create Rh antibodies against the baby’s blood. • Also known as haemolytic disease of the fetus and newborn(HDFN). 18
  • 18. • First demonstrated in rhesus monkey • Blood groups are classified as Rh positive and Rh negative
  • 19. •The Rh factor , Rh+ and Rh- usually refers specifically to the presence or absence of antigen- D •There are two alleles, or genetic variants , of this antigen: D and d. •A person who is Rh- has two recessive traits, dd. Anyone who has at least one D-DD or Dd-is Rh+
  • 20. • A person's Rh type is generally most relevant with respect to pregnancies • If the pregnant woman and her husband are Rh negative, there is no reason to worry about Rh incompatibility
  • 21. •If she is Rh negative and her husband is Rh positive,the baby will inherit the father's blood type ,creating incompatibility between mother and her fetus. •If some of the fetal blood gets into mother's blood stream, her body will produce antibodies. •These antibodies could pass back through the placenta and harm the developing baby's red blood cells, causing very mild to very serious anemia in the fetus.
  • 22. 23 1.Rh-ve mothercarryingRh+ve fetus 2.Entry of fetus Rh+ve RBC into maternalcirculation 3.Development of Rh antibodies by the mother
  • 23. •Usually placenta acts as barrier to fetal blood entering maternal circulation. However, sometimes during pregnancy or birth,fetomaternal haemorrhage (FMH) can occur. The woman’s immune system reacts by producing anti-D antibodies that cause sensitisation
  • 24.
  • 25. •In subsequent pregnancies antibodies can cross placenta and destroy fetal erythrocytes. The haemolytic disease of fetus and new born caused by Rh isoimmunisation can occur during the first pregnancy, but usually sensitisation during the first pregnancy or birth leads to extensive destruction of fetal RBC during subsequent pregnancies
  • 26. • Miscarriage • Abortion • Feto-maternal haemorrage
  • 27. • Rh incompatibility can cause symptoms ranging from very mild to fatal. • Mildest form- Rh incompatibility: 1-Hemolysis (Destruction of the red blood cells) with the release of free hemoglobin into the infant's circulation. 2- Jaundice (Hemoglobin is converted into,bilirubin which causes an infant to become yellow.
  • 28.
  • 29.
  • 30. 1- Hydrops fetalis (Massive fetal red blood cell destruction). It causes anemiaFetal heart failure Death of the infant shortly after delivery.
  • 31. 3 Respiratory distress (if the infant has been delivered) 4 Circulatory collapse. 5 Kernicterus. (Neurological syndrome in extremely jaundiced infants) 6 It occurs several days after delivery and is characterized initially by... A)Loss of the Moro reflex. B)Poor Feeding. C) Decreased activity
  • 32. • At last it may lead to death of the child immediately after its birth
  • 33.
  • 34. 1 There are no any physical symptoms can be seen in rh incompatibility. 2 If the woman just found out she is pregnant,she should undergo blood-type test. This test determines her blood type and Rh factor. 3 Blood test that will determine whether she is Rh positive or Rh negative
  • 35. • Intrauterine transfusion • Elect time of delivery • Exchange transfusion after delivery • Phototherapy after delivery • Top-up transfusion (Hb falls below 7g/dl, prophylactic :oral folate) 36
  • 36. • The fetus can die in utero from severe anaemia and hydrops before he can be delivered. • An intrauterine transfusion can prolong the life in utero of a fetus to a gestation where the risks of prematurity are estimated as being less than those of the Rh disease. This can be done by an: 1.Intraperitoneal transfusion guidedby ultrasound. 2.Umbilical veintransfusion guided by ultrasound. 37
  • 37. Rh-negative blood is either transfused under ultrasoundcontrol. Repeat as necessary, accordingto amniotic optical density, or fetal haematocrit. The intravenous route is becoming increasingly the preferred method.
  • 38. Choose time of induction and best method of delivery • Balance the risks of prematurity (too soon) with that of worsening Rh disease (too late). • Consider the risks of vaginal delivery and be prepared for a lower segment Caesarean section (LSCS). • Usually done only after 34 weeks of gestation. • The paediatric team should be in close and a senior paediatrician present at the delivery • Fresh Rh-negative blood available. 39
  • 39. • Good resuscitation is essential. In an anaemic. premature infant, lung disease is common. It can be due to:  Surfactant deficiency at very early delivery.  Pulmonary oedema from anaemia and hypoproteinaemia.  Hypoplastic lungs secondary to pleural effusions. • In severe Rh haemolytic disease of the newborn, an umbilical artery catheter should be inserted as soon as possible to assess and control PaO2 and pH. • Central venous pressure should be measured.  Drain pleural effusions and ascites at resuscitation. 40
  • 40. Indication for exchange Transfusion: 1. Early: Decisionmainly based oncord (in addition consider history of previously affected babies). • Cord haemoglobin <12g/dl. • Strongly positive Coombs’ test. • Cord bilirubin >85mmol/l. 2.HaemoglobinLate: Usually donefor hyperbilirubinaemia. • The aims:  Treat anaemia.  Washes out IgG antibodies.  Decreases degree of haemolysis.  Removes bilirubin.  Prevents kernicterus.
  • 41. • Placing newborn baby under a halogen or fluorescent lamp with their eyes covered. • Lowers the bilirubin levels in the baby’s blood through photo-oxidation. • During phototherapy, intravenous hydration is required. 42
  • 42.
  • 43. • Anti-D immunoglobulin to all Rh-negative women at 28 and 34 weeks routinely-RAADP Or give anti- D immunoglobulin if she has a:  Therapeutic abortion. Spontaneous abortion/ectopic pregnancy.  Amniocentesis.  Any bleeding in pregnancy/threatened miscarriage.  External Cephalic Version.  After delivery at any gestation within 72Hours. 44
  • 44. DIAGNOSIS Risk for injury from breaking down products of RBCs in greater numbers than normal and functional immaturity of the liver. Goals • Will receive appropriate therapy to accelerate bilirubin excretion. • Will experience no complications from phototherapy. • Will experience no complications from exchange transfusin.
  • 45. • Interrupted family process R/T infant with potentially adverse physiologic response. • Family will receive emotional support. • Family will be prepared for home care of the neonate.
  • 46. • NURSING CARE for Rh incompatibility DURING PHOTOTHERAPY 1.Remove clothing to proper skin exposure. 2.Turn infant frequently to expose all skin area. 3.Record and report jaundice and blood levels of bilirubin. 4.Record and report if any change in body temperature
  • 47. -Be sure the eyes close before applying eye patch to prevent corneal irritation. -Should be loose enough to avoid pressure. -Eye patches should be changed every 8houly and eye care given. 6.Nurse should expect the infant’s stools to be green and the urine dark because of photo degradation products.
  • 48. 7. Serum bilirubin and hematocrit should be monitored during therapy and for 24 hours following therapy. 8. In case of breast milk jaundice stop breast feeding temporarily. 9. Maintain feeding intervals to prevent dehydration.
  • 49.
  • 50.
  • 52.
  • 53.
  • 54. • In addition to cases in which a fetus dies during delivery as deprivation a result of asphyxia if the umbilical cord (oxygen becomes twisted) or difficult labor. • Others can die in utero before labor starts. followed by expulsion of the fetus from the uterus within a few days. • However, in rare instances the dead fetus is not expelled from the uterus at once, but is retained for several weeks.
  • 55. • Fetal death refers to the spontaneous death of a fetus at any time during pregnancy, although the term is often used interchangeably with ‘stillbirth’. • A stillbirth is a death that occurs after 20 weeks of gestation.
  • 56. Intrauterine fetal death: is the clinical term for the death of a baby in the uterus, during pregnancy and before birth. The term is usually used for pregnancy losses that happen after the 20th week of gestation.
  • 57. •In the present investigation the epidemiological factors responsible for intrauterine fetal deaths after 20 week of gestation were studied. •A retrospective study registered and managed of 16882 pregnancies in the Department of Obstetrics and Gynecology, in united state
  • 58. One hundred and three cases of intrauterine fetal deaths were registered and treated expectantly out of 16882 total pregnancies registered during the four year study period.
  • 59. Pregnancy complications: - Pre-eclamptic toxemia - Antepartum haemorrhage : placenta previa, abruptio placentae Pre- existing medical disease and acute illness: - Chronic hypertension - Chronic nephritis - Diabetes - Severe anemia - Hyperpyrexia - Syphilis, Hepatitis, toxoplasmosis etc. Hyperpyrexia
  • 60. • Fetal - Congenital malformation - Rh-incompatibility - Post maturity • External version • Idiopathic 20 –30%
  • 61. • Maternal Complications • Decreased platelets • Decreased fibrinogen • Increased PT/PTT (Clotting times) • Clinical bleeding / oozing from all sites RX involves DELIVERY, pRBC’s, FFP, PLATELETS, Supportive Management
  • 62. • Depression, Anxiety, Psychosocial • Anxiety with future pregnancies • May have repeat losses (depending on causes) • Bleeding ---> can lead to DIC but may only require blood product replacement • Pain, Infection (similar to any other delivery)
  • 63. •Multiple pregnancy •Advanced maternal age •History of fetal demise (IUFD) •Maternal infertility •Maternal haemoconcentration •Maternal colonization with certain pathogens •Small for gestational age infant •Obesity •Paternal age •African American race
  • 64. • Absence of fetal movement • Vaginal bleeding • Abdominal pain • Small uterus than the duration of pregnancy • Sometimes secretion of colostrum occur few days after death of fetus in uterus.
  • 65. • In most patients, the only symptom is decreased fetal movement. An inability to obtain fetal heart tones upon examination suggests fetal demise; however, this is not diagnostic and death must be confirmed by diagnostic tests . • Labor should be induced as soon as possible after diagnosis. Patient responses vary in regard to this recommendation; some wish to begin induction immediately, while others wish to delay induction for a period of hours or days until they are emotionally prepared.
  • 66. • Blood test because it comes negative within a week after the death of the fetus. • The secretion of estriol it is a type of estrogen produced by an active placenta in the mother’s urine falls sharply.
  • 67. • Explain the problem to the woman and her family. Discuss with them the options of expectant or active management. • Medical induction of labor: Medicine is used to start labor and fetus delivered naturally.
  • 68.
  • 69. • Pain management in patients undergoing induction of labor for fetal death is usually easier to manage than in patients with live fetuses. • Higher doses of narcotics are available to the patient and often a morphine is sufficient for successful pain control. Should a patient desire superior pain control to intravenous narcotics, epidural anesthesia should be offered.
  • 70.
  • 71. Diagnosis Anticipatory grieving related to fetal loss Intervention • To give the patient time to gather support from her family and to fathom the reality of the situation. • Provide psychological support. • Provide counseling to the mother as well as family.
  • 72. Nursing health care guidelines at home • Teach the patient to be aware of the signs and symptoms that could indicate postpartum complications: • Pain in the calf of the leg; increase in vaginal bleeding; foul odor of vaginal discharge; fever; burning with urination; persistent mood charge; or a hard, reddened area on the breast.
  • 73. • Explain that the patient intercourse or drive a car until should not have after the postpartum check. • Encourage participation in a bereavement support group, even if the patient and significant other seem to be coping with the loss. • They may be able to help other couples cope.
  • 74.
  • 75.
  • 76.
  • 77. SGA
  • 78. • Cellular hyperplasia • Hyperplasia and hypertrophy • Hypertrophy
  • 79. • Stage I (Hyperplasia) - 4 to 20 weeks - Rapid mitosis - Increase of DNA content
  • 80. • Stage II (Hyperplasia & Hypertrophy) - 20 to 28 weeks - Declining mitosis. - Increase in cell size.
  • 81. • Stage III ( Hypertrophy) - 28 to 40 weeks - Rapid increase in cell size. - Rapid accumulation of fat, muscle and connective tissue. • 95% of fetal weight gain occurs during last 20 weeks of gestations.
  • 82. • Maternal factors • Fetal factors • Placental factors • Environmental factors
  • 83. •Medical disease •Malnutrition  BMI < 19 twice the risk of IUGR •Multiple pregnancy •Smoking (460 gm < then none smoker)
  • 84. •Alcohol •Drugs second  12-fold increase risk of IUGR  Beta- Blockers(Atenolol in trimster, Anticoagulants, Anticonvulsants( phenytoin) •Hypoxemia •Infections  UTI, Malaria, Infections TB, Genital
  • 85. • Small stature/ low pre-pregnancy weight • Teen pregnancy • Primi gravida • Grand multiparity
  • 86. • A Chromosome Defect-  In second trimester 20% SGA fetuses have chromosomal abnormality    Triploid is most common under 26 wks. Trisomy-18 is common after 26 wks . Other are 21(Down’s syndrome), 16, 13, xo (turner’s syndrome).
  • 87. • Exposure to an infection- • German measles (rubella), cytomegalovirus, herpes simplex, tuberculosis, syphilis, or toxoplasmosis, TB, Malaria, Parvo virus
  • 88. • birth defects • (cardiovascular, renal, anencephally, limb defect, etc). • A primary disorder of bone or cartilage. • A chronic lack of oxygen during development (hypoxia • Placenta or umbilical cord defects.
  • 89. • Uteroplacental Insufficiency Resulting From -. –Improper / inadequate trophoblastic invasion and placentation in the first trimester. –Lateral insertion of placenta. –Reduced maternal blood flow to the placental bed.
  • 90. • Fetoplacetal Insufficiency Due To-. –Vascular anomalies of placenta and cord. –Decreased placental functioning mass-. • Small placenta, abruptio placenta, placenta previa, post term pregnancy
  • 91.
  • 92.
  • 93. • High altitude - lower environmental oxygen saturation • Toxins
  • 94. •Symmetric IUGR (33 % of IUGR Infants) •Asymmetric IUGR (55 % of IUGR) •Combined type IUGR (12 % of IUGR)
  • 95. • Height, weight, head circ proportional • Early pregnancy insult: • Commonly due to congenital infection, genetic disorder, or intrinsic factors • Reduced no of cells in fetus • Normal ponderal index • Low risk of perinatal asphyxia • Low risk of hypoglycemia
  • 96. • The ponderal index is used determine those infants normal whose for soft tissue mass is their below stage of skeletal development. Ponderal Index = birth weight x 100 crown-heel length
  • 97. • Typical values are 20 to 25. • Those who have a ponderal index below the 10th % can be classified as SGA • PI is normal in symmetric IUGR. • PI is low in asymmetric IUGR
  • 98. • Later in pregnancy: • Commonly due to utero placental insufficiency, maternal malnutrition, hypoxia, or extrinsic factors • Low ponderal index • Cell number remains same but size is small • Increased risk of asphyxia • Increased risk of hypoglycemia
  • 99. • Growth restriction in the stage of hypertrophy • Brain sparing effect • Head growth remains normal but abdominal girth slows down
  • 100.
  • 101.
  • 102.
  • 103. 1. Normal Small Fetuses- • Have no structural abnormality, umbilical artery & liquor but wt., is less. normal • They are not at risk and do not need any special care.
  • 104. Growth Restricted Fetuses- are due to impaired function. Appropriate & timely or termination can improve placental treatment prospects.
  • 105.
  • 106. Dry wrinkled skin Large head circumference Old man look Cartilaginous ridges on pinna
  • 107. Open eyes Thin umbilical cord Well defined creases Normal reflexes Alert and active Normal cry
  • 109. • Signs of recent wasting - soft tissue wasting - diminished skin fold thickness - decrease breast tissue - reduced thigh circumference • Signs of long term growth failure - Widened skull sutures, large fontanelles - shortened crown – heel length - delayed development of epiphyses
  • 110. • History • Risk factors • Last menstrual period - most precise size of uterus • Time of quickening (detection of fetal movements) • Examination • Maternal serum screening
  • 111. - Notching of the waveform /reduce EDF associated 3-fold increase in risk of FGR. • Combination of un-explain elevated maternal AFP is powerful predictor of adverse perinatal outcome (FGR) • Increase AFP combine with echogenic bowel is strong predictor of FGR
  • 112. • DOPPLER OF THE UMBILICAL ARTERY • Reduced end diastolic flow. • Absent end diastolic flow • Reversed end diastolic flow( severe cases)
  • 113.
  • 114.
  • 115.
  • 116. • Hypoxia - Perinatal asphyxia - Persistent pulmonary hypertension - meconium aspiration • Thermoregulation -Hypothermia due to diminished subcutaneous fat and elevated surface/volume ratio
  • 117. - Hypoglycemia - result from inadequate glycogen stores. - diminished gluconeogenesis. - increased BMR - Hypocalcemia - due to high serum glucagon level, which stimulate calcitonin excretion
  • 118. • Hematologic -hyperviscosity and polycythemia due to increase erythropoietin level sec. to hypoxia • Immunologic -IUGR have increased protein catabolism and decreased in protein, prealbumin and immunoglobulins, which decreased humoral and cellular immunity.
  • 119. • Fetal distress, • Hypoxia, Acidosis and Low Apgar Score at birth. Increased perinatal morbidity and mortality • Grade 3-4 intraventricular haemorrhage • Necrotizing enterocolitis
  • 120. • BIOPHYSICAL • HC:AC • Brfore 32 wks • 32—34 wks more than 1 app 1 • FEMUR LENGTH • FL:AC IS 22at all gest wks from 21 wks to term • More than 23.5 indicate IUGR
  • 121. • AFI • <2 Suggest IUGR • PI
  • 122. • MUMMIFICATION • KMC • NESTING • DELAY BATH • WARMER
  • 123. • VENTILATOR • C PAP • 02 SUPPLEMENTATION
  • 124. • <30– IV FLUIDS, NG ,KATORI, BREAST FEEDS • 30—34 NG ,KATORI, BREAST FEEDS • >34 KATORI, BREAST FEEDS
  • 125. • Vital signs • Activity and behaviour. • Color; Pink, pale, grey, blue, yellow. • Tissue perfusion • Fluids, electrolytes and ABG's.
  • 126.
  • 127.
  • 128. • Bronchopulmonary dysplasia • Metabolic disturbances and hypoglycemia • Polycytemia • Hypothermia • Impaired cognitive function and cerebral paresis
  • 129. • ASPIRIN THERAPY • Other forms of treatment that have been studied are • nutritional supplementation, • zinc supplementation, • fish oil, • hormones and • oxygen therapy
  • 130. Diagnosis • Impaired nutritional status less then body requirement related to malnutrition. Intervention • To correct malnutrition by providing balanced diet. • To take extra calories from normal i.e. 300 calories extra. • To provide nutritious foods, juices, fruits etc.
  • 131. Diagnosis • Decreased uteroplacental circulation related to reduced blood flow to maternal surface or placental cause. Intervention • Adequate bed red in left lateral position. • Provide low dose of aspirin i.e. 50 mg daily. • Prove o2 to mother at the rate of 2.5 L/min by nasal prong for short term for prolongation of pregnancy.
  • 132. Diagnosis • Decreased knowledge status of mother related to IUGR, its complication to baby. Intervention • Provide knowledge to the mother. • Provide health education to mother related to self care as well as related to diet. • Provide detailed information about her condition of baby as well as complication for baby.
  • 133. Risk for infection related to poor immunity Goal Care at neonatal intensive care unit Intervention • The NICU should be warm, free from excessive sound smoothing light. • Protection from infection should be ensured by aseptic measures and effective hand washing. • Rough handling and painful procedure should be avoided. • Baby should be placed on soft comfortable, “nestled” and cushioned bed. • Continuous monitoring of the baby’s clinical status are vital aspects.
  • 134. Decreased body temperature related to IUGR Goal Maintenance of stable body temperature Intervention • Baby should be received in a pre warmed radiant warmer or incubator. Environmental temperature should be maintained according to baby’s weight and age. • Baby’s skin temperature should be maintained 36.5 to 37.5 degree celcious. • Baby birth weight of less than 1200gm should be cared in the NICU incubator with 60 to 70 % humidity, oxygen and thermo nutral environment for better thermal control and prevent heat loss.
  • 135. Decreased body weight of baby related to IUGR. Goal Maintenance of nutrition and hydration Intervention • Caloric needs of non-growing LBW babies during first week of life are 60 kcal/ kg/ day on 7th is to be stepped up gradually to 100 on 14th day and about 120-150 on 21st day, to maintain satisfactory growth. • Human milk is the first choice of nutrition for all LBW babies. Colostrums, hind milk, foremilk, and preterm milk help faster growth of baby. • If breast milk is not available cows milk in proportion of 1:1 (milk: water) for 1st month and 2:1 during second month is an alternative substitute.
  • 137. TITLE - Study of causes and complications of intra uterine fetal death (IUFD) OBJECTIVES - This study were to study the causes of Intra Uterine Fetal Death (IUFD), associated complications and to suggest preventive measures. METHODS - Study design: retrospective observational study. This study was carried out over a period of 3 months (April 2014- June 2014) at a tertiary care hospital. Inclusion criteria was all IUFD >20 weeks of gestation.
  • 138. Out of 1850 total births during the study period 80 IUFD occurred. Hence proportion of IUFD was 4.3%. In this study, Still Birth Rate (SBR) as per WHO criteria (28 weeks) was 22.1 per 1000. Registered patients were 24 (30%) whereas 56 (70%) were emergency admissions. Majority of cases, 48 (60%) were multigravidae with past obstetric history of abortion and IUFD in 13 (16.2%) and 9 (11.2%) respectively. In 31 (38.7%) no identifiable cause of IUFD was found whereas cause was identified in 49 (61.3%).
  • 139.  who had who had  care.A significant proportion of IUFD is Anemia, PIH, accidental haemorrhage were leading causes of IUFD. Majority of women IUFD were emergency admission not received adequate antenatal preventable by health education to patients and community for regular antenatal care, about warning signs during antenatal period, hospital delivery and early referral.